Clinician and Patient Perspectives on the Exchange of Sensitive Social Determinants of Health Information.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Oct 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: epublish

Résumé

Social determinant of health (SDOH) data are essential to individualized care and reducing health disparities. However, there is little standardization in the way that SDOH data are collected, and barriers to increasing the collection of such data exist at both the patient and clinician levels. To evaluate clinician, patient, and care partner perspectives on the barriers to and facilitators of patients sharing SDOH information with their clinicians. This qualitative study included clinicians, patients, and care partners across the United States. Focus groups were conducted between September 2022 and February 2023 to understand the experience of collecting, documenting, and exchanging SDOH data. Rapid assessment procedures were used to analyze focus group transcripts, creating summaries, codes, and themes mapped directly to the project research questions. A total of 235 individuals participated, including 109 (46.4%) clinicians (60 [55.0%] male; 25 [22.9%] Asian, 2 [1.8%] Black, and 74 [67.9%] White) and 126 (53.6%) patients and care partners (45 [35.7%] male; 1 [0.8%] Asian, 48 [38.1%] Black, and 64 [50.8%] White). Clinicians and patients agreed that SDOH data are important for clinicians to know. Both clinicians and patients wanted a structured, standardized way to collect SDOH data in the future, accompanied by time for more in-depth discussion during the visit. However, they highlighted numerous issues that impact collecting these data, including beliefs about how the information will be used, the clinician-patient relationship, having enough of the right staff, time needed to collect SDOH information, and technology used to collect the data (eg, usability, standardization). This qualitative study of the experience of collecting, documenting, and exchanging SDOH data underscores the ongoing barriers to widespread adoption of uniform approaches to SDOH data documentation as well as factors that may help lower those barriers, such as trusting patient-clinician relationships, greater transparency in how the data will be used, and targeted resources. A multifaceted approach to addressing the concerns raised by clinicians, patients, and care partners is required to ensure that such data can be captured in a way that improves care and allows for progress toward an equitable health care system.

Identifiants

pubmed: 39480419
pii: 2825509
doi: 10.1001/jamanetworkopen.2024.44376
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2444376

Auteurs

Catherine M DesRoches (CM)

Department of Medicine, Harvard Medical School, Boston, Massachusetts.
OpenNotes, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Deborah Wachenheim (D)

OpenNotes, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Annalays Garcia (A)

OpenNotes, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Kendall Harcourt (K)

OpenNotes, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

JaWanna Henry (J)

Department of Health and Human Services, Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology, Washington, DC.

Ria Shah (R)

OpenNotes, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Vaishali Patel (V)

Department of Health and Human Services, Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology, Washington, DC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH